Roche Holding's support for Ebola testing is sparking discussions about fair value.
Roche's recent initiative to support Ebola testing has caught attention regarding its fair value. This news comes amid ongoing discussions about Roper Technologies’ strategic moves and their impact on shareholders.
Investor takeaway: Keep an eye on how Roche's developments might affect perceptions of value in related sectors.
Advertisement
Roper Technologies Inc
ROP.US
ROP.US
Roper Technologies Inc
WealthAwesomeMarket cap
$35.46B
P/E
15.1x
Div. yield
0.98%
Div. / share
$3.56
52W high
$514.14
52W low
$304.43
1W change
+0.71%
Beta
0.75
Analyst Price Targets
Based on 19 analysts covering ROP · as of Oct 5, 2026
Wall Street analysts forecast ROP stock price to rise 20.6% over the next 12 months.
Consensus
Buy3.58 / 5.00
Avg. Target
C$439.43
+20.6% Upside
Current Price
C$364.23
Last close
Analyst Breakdown (19 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ROP's historical volatility
30-Day Vol
26.8%
Annualized
90-Day Vol
31.0%
Annualized
Trend (90d)
+19.6%
Annualized drift
90d Mean
C$390.62
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$372.82 | C$339.85 – C$408.99 |
| 60 trading days | C$381.62 | C$334.78 – C$435.01 |
| 90 trading days | C$390.62 | C$332.74 – C$458.57 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Roper Technologies Shares Up 1.58% Amid Recent News
Roper Technologies closed at US$365.44, with a trading volume of 51,212 shares, slightly below its 20-day average.
Roche's Ebola Testing Support Announced
Roche Holding has announced its support for Ebola testing, leading to renewed discussions about its fair value. This aligns with Roper Technologies (ROP.US), which closed at US$365.44, reflecting a 1.58% increase in its share price. In the past week, Roper's stock has gained 0.71%, but it has decreased by 7.71% over the past month and 15.55% year-to-date. Roche's initiative may indirectly affect how investors view fair value in Roper and similar companies.
Advertisement
Roper Technologies' Recent Trading Activity
Roper Technologies (ROP.US) saw its share price rise by 1.58%, closing at US$365.44. The trading volume was 51,212 shares, about 0.98 times its 20-day average of 890,431 shares, indicating lower trading activity compared to recent trends. The stock is currently below its 50-day moving average of US$390.53, showing a 6.4% decline, but is slightly above its 200-day moving average of US$368.30, which is 0.8% higher. The 52-week range for Roper is between US$304.43 and US$514.14, positioning the current price at about 29% of this range.
Market Sentiment and Future Considerations
As discussions about fair value continue, investors should pay attention to how Roche's actions might influence market sentiment toward Roper Technologies. Analysts have an average target price of US$439.43 for Roper, suggesting a potential upside of 20.2% from current levels. The company has a P/E ratio of 15.10, reflecting its valuation in relation to earnings, and a profit margin of 30.2% contributes to its financial stability. Roper's return on equity (ROE) stands at 13.1%, indicating efficient management of equity capital.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
